The cerebrospinal fluid albumin/serum albumin (Qalb) ratio, which reflects impairment of the blood-brain barrier, was significantly higher in patients with CIDP than in those with GBS (14.34 vs. 8.25, p < 0.05) (Table 2). The gene discussed is ALB; the disease is Guillain-Barre syndrome.